UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Long-term effects of fenofibrate on VLDL and HDL subspecies in participants with type 2 diabetes mellitus

Diabetologia, 2007-10, Vol.50 (10), p.2067-2075

2007

Volltextzugriff (PDF)

Low‐grade inflammation, endothelial activation and carotid intima‐media thickness in type 2 diabetes

Journal of internal medicine, 2004-08, Vol.256 (2), p.119-127

2004

Volltextzugriff (PDF)

Increased augmentation of central blood pressure is associated with increases in carotid intima-media thickness in type 2 diabetic patients

Diabetologia, 2005-08, Vol.48 (8), p.1654-1662

2005

Volltextzugriff (PDF)

Long-term effects of fenofibrate on VLDL and HDL subspecies in participants with type 2 diabetes mellitus

Diabetologia, 2007-12, Vol.50 (12), p.2611-2613

2007

Volltextzugriff (PDF)

ApoCIII-Enriched LDL in Type 2 Diabetes Displays Altered Lipid Composition, Increased Susceptibility for Sphingomyelinase, and Increased Binding to Biglycan

Diabetes (New York, N.Y.), 2009-09, Vol.58 (9), p.2018-2026

2009

Volltextzugriff (PDF)

Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes

Atherosclerosis, 2003-02, Vol.166 (2), p.387-394

2003

Volltextzugriff (PDF)

Decreased High-Density Lipoprotein (HDL) Particle Size, Preβ-, and Large HDL Subspecies Concentration in Finnish Low-HDL Families: Relationship With Intima-Media Thickness

Arteriosclerosis, thrombosis, and vascular biology, 2006-04, Vol.26 (4), p.897-902

2006

Volltextzugriff (PDF)

Alterations of lipids and apolipoprotein CIII in very low density lipoprotein subspecies in type 2 diabetes

Diabetologia, 2005-06, Vol.48 (6), p.1207-1215

2005

Volltextzugriff (PDF)

Globular adiponectin stimulates glucose transport in type 2 diabetic muscle

Diabetes/metabolism research and reviews, 2008-10, Vol.24 (7), p.554-562

2008

Volltextzugriff (PDF)

Fenofibrate Treatment and Renal Function in Type 2 Diabetes: FIELD Helsinki Substudy

MD conference express, 2007-11, Vol.7 (6), p.11-11

2007

Volltextzugriff (PDF)

Abstract: 70 CHANGES IN LIPOPROTEIN COMPOSITION IN DIABETIC DYSLIPIEMIA

Atherosclerosis. Supplements, 2009-06, Vol.10 (2), p.e31-e31

2009

Volltextzugriff (PDF)

EFFECTS OF 5-YEAR FENOFIBRATE TREATMENT ON ARTERIAL STIFFNESS AND CAROTID INTIMA-MEDIA THICKNESS IN TYPE 2 DIABETES: FIELD HELSINKI SUBSTUDY

Atherosclerosis. Supplements, 2008-05, Vol.9 (1), p.6-6

2008

Volltextzugriff (PDF)

WO10-OR-3 MECHANISM FOR APOLIPOPROTEIN CIII-ENHANCED ATHEROGENICITY OF LDL IN TYPE 2 DIABETES

Atherosclerosis. Supplements, 2007-06, Vol.8 (1), p.10-10

2007

Volltextzugriff (PDF)

We-P11:62 Reduction of large VLDL particles by fenofibrate is associated with reduction of small dense LDL in type 2 diabetes: Field Helsinki substudy

Atherosclerosis. Supplements, 2006, Vol.7 (3), p.359-360

2006

Volltextzugriff (PDF)

T04-P-018 Determinants of remnant-like particlecholesterol in type 2 diabetes

Atherosclerosis. Supplements, 2005-04, Vol.6 (1), p.156-156

2005

Volltextzugriff (PDF)

Th-P15:37 Decreased HDL particle size, preβ- and large HDL subspecies concentration in finnish low HDL families. Relationship with intima-media-thickness (IMT)

Atherosclerosis. Supplements, 2006, Vol.7 (3), p.500-500

2006

Volltextzugriff (PDF)

MS49 THE HELSINKI FIELD SUBSTUDY: EFFECTS OF FENOFIBRATE AND HOMOCYSTEINE ON IN VITRO CHOLESTEROL EFFLUX POTENTIAL OF HDL AND PLASMA

Atherosclerosis. Supplements, 2010-06, Vol.11 (2), p.120-120

2010

Volltextzugriff (PDF)

PPARα: an emerging therapeutic target in diabetic microvascular damage

Nature reviews. Endocrinology, 2010-08, Vol.6 (8), p.454-463

2010

Volltextzugriff (PDF)

Microbial community structure and characteristics of the organic matter in soils under Pinus sylvestris, Picea abies and Betula pendula at two forest sites

Biology and fertility of soils, 2001-01, Vol.33 (1), p.17-24

2001

Volltextzugriff (PDF)

High density lipoprotein structural changes and drug response in lipidomic profiles following the long-term fenofibrate therapy in the FIELD substudy

PloS one, 2011-08, Vol.6 (8), p.e23589-e23589

2011

Volltextzugriff (PDF)

Effects of Long-Term Fenofibrate Treatment on Markers of Renal Function in Type 2 Diabetes: The FIELD Helsinki substudy

Diabetes care, 2010-02, Vol.33 (2), p.215-220

2010

Volltextzugriff (PDF)

Serum, but not monocyte macrophage foam cells derived from low HDL-C subjects, displays reduced cholesterol efflux capacity

Journal of lipid research, 2009-02, Vol.50 (2), p.183-192

2009

Volltextzugriff (PDF)

Long-Term Effects of Fenofibrate on Carotid Intima-Media Thickness and Augmentation Index in Subjects With Type 2 Diabetes Mellitus

Journal of the American College of Cardiology, 2008-12, Vol.52 (25), p.2190-2197

2008

Volltextzugriff (PDF)

Does short-term heating of forest humus change its properties as a substrate for microbes?

Soil biology & biochemistry, 2000-02, Vol.32 (2), p.277-288

2000

Volltextzugriff (PDF)

Macrophage cholesterol efflux to plasma and HDL in subjects with low and high homocysteine levels: A FIELD substudy

Atherosclerosis, 2011-11, Vol.219 (1), p.259-265

2011

Volltextzugriff (PDF)

1 – 25 von 42

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(42)

Sprache

Englisch
(42)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Science & Technology
(22)
Life Sciences & Biomedicine
(20)
Humans
(16)
Biological And Medical Sciences
(15)
Male
(15)
Middle Aged
(14)
Female
(13)
Medical Sciences
(11)
Aged
(9)
Diabetes
(9)
Endocrinology & Metabolism
(9)
Type 2 Diabetes
(9)
Diabetes. Impaired Glucose Tolerance
(8)
Endocrine Pancreas. Apud Cells
(8)
Endocrinopathies
(8)
Etiopathogenesis. Screening. Investigations. Target Tissue Resistance
(7)
Fenofibrate - Therapeutic Use
(7)
Atherosclerosis
(6)
Cardiovascular Disease
(6)
High Density Lipoprotein
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Long-term effects of fenofibrate on VLDL and HDL subspecies in participants with type 2 diabetes mellitus

Low‐grade inflammation, endothelial activation and carotid intima‐media thickness in type 2 diabetes

Increased augmentation of central blood pressure is associated with increases in carotid intima-media thickness in type 2 diabetic patients

Long-term effects of fenofibrate on VLDL and HDL subspecies in participants with type 2 diabetes mellitus

ApoCIII-Enriched LDL in Type 2 Diabetes Displays Altered Lipid Composition, Increased Susceptibility for Sphingomyelinase, and Increased Binding to Biglycan

Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes

Decreased High-Density Lipoprotein (HDL) Particle Size, Preβ-, and Large HDL Subspecies Concentration in Finnish Low-HDL Families: Relationship With Intima-Media Thickness

Alterations of lipids and apolipoprotein CIII in very low density lipoprotein subspecies in type 2 diabetes

Globular adiponectin stimulates glucose transport in type 2 diabetic muscle

Fenofibrate Treatment and Renal Function in Type 2 Diabetes: FIELD Helsinki Substudy

Abstract: 70 CHANGES IN LIPOPROTEIN COMPOSITION IN DIABETIC DYSLIPIEMIA

EFFECTS OF 5-YEAR FENOFIBRATE TREATMENT ON ARTERIAL STIFFNESS AND CAROTID INTIMA-MEDIA THICKNESS IN TYPE 2 DIABETES: FIELD HELSINKI SUBSTUDY

WO10-OR-3 MECHANISM FOR APOLIPOPROTEIN CIII-ENHANCED ATHEROGENICITY OF LDL IN TYPE 2 DIABETES

We-P11:62 Reduction of large VLDL particles by fenofibrate is associated with reduction of small dense LDL in type 2 diabetes: Field Helsinki substudy

T04-P-018 Determinants of remnant-like particlecholesterol in type 2 diabetes

Th-P15:37 Decreased HDL particle size, preβ- and large HDL subspecies concentration in finnish low HDL families. Relationship with intima-media-thickness (IMT)

MS49 THE HELSINKI FIELD SUBSTUDY: EFFECTS OF FENOFIBRATE AND HOMOCYSTEINE ON IN VITRO CHOLESTEROL EFFLUX POTENTIAL OF HDL AND PLASMA

PPARα: an emerging therapeutic target in diabetic microvascular damage

Microbial community structure and characteristics of the organic matter in soils under Pinus sylvestris, Picea abies and Betula pendula at two forest sites

High density lipoprotein structural changes and drug response in lipidomic profiles following the long-term fenofibrate therapy in the FIELD substudy

Effects of Long-Term Fenofibrate Treatment on Markers of Renal Function in Type 2 Diabetes: The FIELD Helsinki substudy

Serum, but not monocyte macrophage foam cells derived from low HDL-C subjects, displays reduced cholesterol efflux capacity

Long-Term Effects of Fenofibrate on Carotid Intima-Media Thickness and Augmentation Index in Subjects With Type 2 Diabetes Mellitus

Does short-term heating of forest humus change its properties as a substrate for microbes?

Macrophage cholesterol efflux to plasma and HDL in subjects with low and high homocysteine levels: A FIELD substudy

Suchergebnisse filtern